ALNOV:EPA
Novacyt SA
0,44 €
arrow_upward
+1,38%(+0,0060) 1D
18-ноя., 17:35:20 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,44 €
High
0,44 €
Low
0,43 €
Mkt. cap
32,30 млн
Avg. vol.
139,48 миң
Volume
150,99 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,44 €
High
0,44 €
Low
0,43 €
Mkt. cap
32,30 млн
Avg. vol.
139,48 миң
Volume
150,99 миң
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
ChartMill
·
43 мүнөт мурун
S&P 500 Most Active Stocks on Nov. 18: AES Leads Volume, Freeport-McMoRan Drops 6.45%
ChartMill
·
1 саат мурун
S&P 500 Unusual Volume Movers: Nov. 18, 2026
TradingView
·
4 саат мурун
S&P 500, Nasdaq find footing as Nvidia treads water
Traders Union
·
29 мүнөт мурун
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded2006-ж., 3-июл.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com